Risk factor analysis for outcome in 263 patients
| Variable . | OS at 2 years from relapse (%) . | P . | |
|---|---|---|---|
| Univariate . | Multivariate . | ||
| Interval from first transplant to relapse | |||
| < 5 mo (median) | 7.5 ± 2 | < .0001 | < .001 |
| > 5 mo | 20.6 ± 4 | ||
| Stage at first transplant | |||
| CR1 | 15.7 ± 3 | .46 | ND |
| CR2/3 | 9.4 ± 4 | ||
| Donor type (1st transplant) | |||
| HlA identical sibling | 17.9 ± 3 | .006 | NS |
| other | 6.9 ± 3 | ||
| Year of transplant | |||
| Y ≤ 2005 | 19 ± 3 | .01 | NS |
| Y > 2005 | 4.2 ± 2 | ||
| Age > 56 y (median) | |||
| ≤ 56 y | 17 ± 3 | .18 | ND |
| > 56 y | 11.3 ± 3 | ||
| Cytogenetic subgroups27 | |||
| Good | 19 ± 11 | .71 | ND |
| Intermediate | 12 ± 3 | ||
| Poor | 14 ± 5 | ||
| Missing | 22 ± 7 | ||
| ATG for GvHD prophylaxis | |||
| No | 12 ± 3 | 0.19 | ND |
| Yes | 18 ± 4 | ||
| TBI for conditioning | |||
| No | 18 ± 3 | 0.16 | ND |
| Yes | 6 ± 3 | ||
| Blast in BM at relapse | |||
| < 27 (median) | 22.1 ± 4 | < .0001 | < .001 |
| > 27 | 7 ± 2 | ||
| Acute GVHD after RIC HSCT | |||
| No | 15.6 ± 3 | .02 | .017 |
| Yes | 10.3 ± 4 | ||
| Chronic GVHD after RIC HSCT | |||
| No | 10.9 ± 2 | .01 | NS |
| Yes | 25.3 ± 6 | ||
| Variable . | OS at 2 years from relapse (%) . | P . | |
|---|---|---|---|
| Univariate . | Multivariate . | ||
| Interval from first transplant to relapse | |||
| < 5 mo (median) | 7.5 ± 2 | < .0001 | < .001 |
| > 5 mo | 20.6 ± 4 | ||
| Stage at first transplant | |||
| CR1 | 15.7 ± 3 | .46 | ND |
| CR2/3 | 9.4 ± 4 | ||
| Donor type (1st transplant) | |||
| HlA identical sibling | 17.9 ± 3 | .006 | NS |
| other | 6.9 ± 3 | ||
| Year of transplant | |||
| Y ≤ 2005 | 19 ± 3 | .01 | NS |
| Y > 2005 | 4.2 ± 2 | ||
| Age > 56 y (median) | |||
| ≤ 56 y | 17 ± 3 | .18 | ND |
| > 56 y | 11.3 ± 3 | ||
| Cytogenetic subgroups27 | |||
| Good | 19 ± 11 | .71 | ND |
| Intermediate | 12 ± 3 | ||
| Poor | 14 ± 5 | ||
| Missing | 22 ± 7 | ||
| ATG for GvHD prophylaxis | |||
| No | 12 ± 3 | 0.19 | ND |
| Yes | 18 ± 4 | ||
| TBI for conditioning | |||
| No | 18 ± 3 | 0.16 | ND |
| Yes | 6 ± 3 | ||
| Blast in BM at relapse | |||
| < 27 (median) | 22.1 ± 4 | < .0001 | < .001 |
| > 27 | 7 ± 2 | ||
| Acute GVHD after RIC HSCT | |||
| No | 15.6 ± 3 | .02 | .017 |
| Yes | 10.3 ± 4 | ||
| Chronic GVHD after RIC HSCT | |||
| No | 10.9 ± 2 | .01 | NS |
| Yes | 25.3 ± 6 | ||
ND indicates not done; and NS, not significant.